Wire · regulatory
AMA Opposes HHS Proposal to Expand Access to Unapproved Peptides
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 18 November 2026 · Fusion42 review
The American Medical Association (AMA) opposes a US Department of Health and Human Services (HHS) proposal to allow compounded use of unapproved peptides, citing patient safety risks and calling for these substances to undergo full FDA review.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You must prepare for potential tightening of FDA approval standards on compounded peptides as the AMA pushes back against loose regulations. This raises the bar for safety proof before market access in peptide-based treatments.
◆ Coverage
1 source · 18 Nov 2026
◆ Related on Wire
◆ Topics